JPRN-jRCT1080221685未知3 期
ZO-Y60 Phase III clinical trial
适应症
试验速览
- 阶段
- 3 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 15age old 至 <= 64age old（—）
- 性别
- All
入选标准
- •Patients with gasstrointestinal disease.
- •Out-patients who signed a written informed consent.
- •If patient age is under 20 years old, a written informed consent have to be obtained from both participant and his/her parent(s).
排除标准
- 未提供
研究者
相似试验
未知
3 期
ZO-Y49 PhaseIII clinical trialGynecologic DiseaseJPRN-jRCT2080220729ZERIA Pharmaceutical Co.,Ltd.
已完成
3 期
ZO-SA0 PhaseIII clinical trialCardiovascular diseaseJPRN-jRCT1080222354Zeria Pharmaceutical Co., Ltd.60
已完成
2 期
Z-206 Phase III Clinical Trial -Investigation on the remission–maintaining effect in patients with Crohn's disease in remission phasePatients with Crohn's disease in remission phaseJPRN-C000000301Zeria Pharmaceutical Co.,LTD.40
已完成
3 期
Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with Crohn's disease in active phasePatients with Crohn's disease in active phaseJPRN-C000000300Zeria Pharmaceutical Co.,LTD60
未知
3 期
Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with Crohn's disease in active phasePatients with Crohn's disease in active phaseJPRN-jRCT2080220189Zeria Pharmaceutical Co., Ltd.